The 10 deadliest cancers, and why there's no cure
The deadliest cancers aren't necessarily the ones that kill the most people, overall. They're the ones with the lowest survival rates.
Source: livescience.com
Surveillance Research Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Surveillance Research Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Surveillance Research Program Today - Breaking & Trending Today
TECVAYLI® (teclistamab-cqyv) biweekly dosing approved by the U.S. FDA for the treatment of patients with relapsed or refractory multiple myeloma
/PRNewswire/ -- Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application...
Source: prnewswire.com
U.S. FDA Approves TALVEY™ (talquetamab-tgvs), a First-in-Class Bispecific Therapy for the Treatment of Patients with Heavily Pretreated Multiple Myeloma
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has granted...
Source: prnewswire.com
Bariatric Surgery is Associated with Reduced Risk of Pancreatic Cancer: Analysis of a US National Database
A history of bariatric surgery was associated with up to 50% reduced risk of PDAC among a national cohort.
Source: hcplive.com
New CLL Meds: Improved Survival Rates, 1990–2018
Newly published data indicates that widely available medications for chronic lymphocytic leukemia (CLL) have steadily improved overall survival rates over most of the past three decades.
Source: medscape.com